← Open Payments lookup

ADAM LOOSE: Open Payments

NPI 1295216091 · LEXINGTON, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$8,155 in 92 payments from 11 companies in 2025. Trend: 2023 $12,887 · 2024 $16,040 · 2025 $8,155

Consulting: $4,857Food & beverage: $1,742Travel & lodging: $1,444Education: $111
CompanyPaymentsAmount
E.R. Squibb & Sons, L.L.C.29$6,925
Alkermes, Inc.14$429
Otsuka America Pharmaceutical, Inc.12$198
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)21$197
Teva Pharmaceuticals USA, Inc.4$154
Lundbeck LLC4$88
Janssen Pharmaceuticals, Inc3$66
Neurocrine BioSciences, Inc.2$40
Vanda Pharmaceuticals Inc.1$27
Supernus Pharmaceuticals, Inc.1$16

Products named: COBENFY, ARISTADA, CAPLYTA, ABILIFY ASIMTUFII, ABILIFY MAINTENA, REXULTI, INVEGA SUSTENNA, UZEDY.

Industry payments across KY — which companies pay providers there.